Mercer Global Advisors Inc Adma Biologics, Inc. Transaction History

Mercer Global Advisors Inc

  • $45.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$3.08 - $4.52 $616 - $903
-200 Reduced 1.27%
15,500 $70,000
Q3 2023

Nov 13, 2023
BUY
$3.47 - $4.61 $2,429 - $3,227
700 Added 4.67%
15,700 $56,000
Q2 2022

Aug 10, 2022
BUY
$1.43 - $2.2 $21,450 - $33,000
15,000 New
15,000 $30,000

Others Institutions Holding ADMA

# of Institutions
326
Shares Held
190M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.31B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email